Literature DB >> 2253239

Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization.

F Z Bischoff1, S O Yim, S Pathak, G Grant, M J Siciliano, B C Giovanella, L C Strong, M A Tainsky.   

Abstract

Families of patients with the Li-Fraumeni cancer syndrome have an inherited pattern of sarcomas and various other types of cancers that follow a dominant mode of transmission, an early age of onset, and exhibit multiple primary tumors. As soft tissue sarcomas (including fibrosarcomas) are frequently observed with this syndrome, the in vitro growth characteristics of fibroblasts derived from skin biopsies of Li-Fraumeni syndrome patients were studied. Control fibroblasts maintained a normal morphology and eventually senesced in culture. Fibroblasts from seven of eight affected individuals developed changes in morphology, anchorage-independent growth, and chromosomal abnormalities. In a fashion similar to that of fibroblasts from normal donors they underwent a growth crisis during which their growth was slow, but they continued to grow past the point at which control samples had stopped dividing (35 population doublings). Fibroblasts from Li-Fraumeni cancer patients escape senescence, growing well beyond 35 population doublings with growth rates similar to early-passage cells. Patient fibroblasts maintain the morphology of a transformed cell but remain nontumorigenic in nude mice. These observations of the behavior of fibroblasts from patients with the Li-Fraumeni syndrome may have predictive value for the determination of gene carriers within these families who are at high risk of cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253239

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  78 in total

1.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.

Authors:  Rozita Bagheri-Yarmand; Anna Biernacka; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

4.  Mutant p53 cooperates with ETS2 to promote etoposide resistance.

Authors:  Phi M Do; Lakshman Varanasi; Songqing Fan; Chunyang Li; Iwona Kubacka; Virginia Newman; Krishna Chauhan; Silvano Rakeem Daniels; Maurizio Boccetta; Michael R Garrett; Runzhao Li; Luis A Martinez
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

5.  Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway.

Authors:  Qunfang Li; Michael A Tainsky
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

6.  Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.

Authors:  Connie Chao; Deron Herr; Jerold Chun; Yang Xu
Journal:  EMBO J       Date:  2006-06-01       Impact factor: 11.598

7.  ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.

Authors:  H Vaziri; M D West; R C Allsopp; T S Davison; Y S Wu; C H Arrowsmith; G G Poirier; S Benchimol
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

8.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

9.  Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.

Authors:  P K Liu; E Kraus; T A Wu; L C Strong; M A Tainsky
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

10.  The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.

Authors:  N C Denko; A J Giaccia; J R Stringer; P J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.